glp-1 lawsuits claiming Ozempic, other GLP-1s led to blindness become second mass litigation over the drugs Ozempic® Lawsuit | July 2026

Late 2024 to 2025 : After a GLP-1 NAION study was published potentially linking semaglutide GLP-1 medications to a higher risk of developing NAION, lawsuits and investigations began focusing on whether manufacturers failed to adequately warn about the risk of sudden vision loss, optic nerve damage, and permanent blindness

suggest that this peptide also interacts with ghrelin receptors located within the nervous system, potentially promoting signals associated with an observable elevation in hunger hormone signaling

By applying an After Party Hangover Patch before or after drinking, you can ensure that your body has the tools it needs to recover quickly and effectively

In the UK, prednisolone is typically prescribed directly

Karla works with eligible patients exploring wellness-focused peptide programs, including GLOW Blend, BPC-157, TB-500, GHK-Cu, Sermorelin, Tesamorelin, Ipamorelin, CJC-1295, KLOW, Wolverine Blend, NAD+ therapy, and physician-guided medical weight loss programs